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Introduction
Mental health is “a state of  well-being in which every 
individual realizes his or her own potential, can work 
productively and fruitfully, and is able to contribute to 
her or his community.”(1) Mental illness often attracts a 
lower priority than physical illness in post-conflict and low 
and middle-income societies but the two are inextricably 
linked. Untreated and unrecognized mental illness adds 
substantially to poor health. Neuropsychiatric conditions, 
such as depression and substance abuse, account for 9.8% 
of  total disease in low and middle income countries, with 
depression the leading cause of  years lived with disability 
(2). While probably greatly underestimated, more than 
800,000 people annually commit suicide with the majority 
(86%) coming from low and middle-income countries (3). 
Additionally, untreated mental disorders are associated 
with heart disease, stroke, injury, and impaired growth 
and development in children (3). Mental illness has a 
profound and often underestimated impact on the health 
and functioning of  individuals and communities across 
post-conflict societies. 
Mental health is particularly important for South 
Sudan as the majority of  the population has been exposed 
to high rates of  violence, displacement, and political and 
social insecurity. Mental health data from South Sudan is 
limited. One post-conflict study from Juba found that 36% 
of  the sampled population (n=1,242) met criteria for post-
traumatic stress disorder (PTSD) and 50% for depression 
(4). Another study, conducted in northern Uganda and 
South Sudan, found the prevalence of  PTSD was 46% 
among South Sudanese refugees and 48% among South 
Sudanese who stayed in the country (5). These studies 
indicate a high prevalence of  mental illness in South 
Sudan as well as the potential for an increase in psychiatric 
disease as more refugees and internally displaced persons 
return home. As South Sudan attempts to reconcile recent 
memories of  war with optimism for the future, we must 
pay close attention to its citizens’ mental health.
Health care providers in South Sudan must become 
aware of  the high prevalence of  mental illness, its 
associated stigma, and know how to screen, diagnose and 
treat common mental disorders. Part I of  this two-part 
series provides an overview of  the common psychiatric 
conditions seen in post-conflict societies and general 
medical settings with a focus on depression and PTSD. 
Part II will focus on anxiety and substance (including 
alcohol) abuse. Brief  explanations, screening questions to 
assess risk, signs and symptoms, and treatment suggestions 
are provided for each condition. 
Depression 
Depression is a common condition world-wide and 
particularly in post-conflict settings.  Studies from post-
conflict South Sudan found rates of  depression as high as 
50% (4). Untreated depression often results in neglect of  
personal and professional responsibilities and significantly 
impacts daily life. It also negatively affects the lives of  
families. Severe depression may lead to suicide. A study of  
South Sudanese ex-combatants found that 15% reported 
wishing they were dead, or had thoughts of  self  harm 
(6). The main symptoms of  depression include low mood 
(sadness) or loss of  interest in usually enjoyed activities 
(anhedonia) every day, most of  the day for at least two 
weeks plus four additional symptoms listed in table 1.
Screening: The following questions help to assess for 
depression (see table 2). The first two are adapted from 
the Patient Health Questionnaire (PHQ-2) screening tool, 
which is used to assess frequency of  depressed mood and 
low interest in the past month. Each question is scored as 
0 (NO feelings of  sadness or hopelessness or continued 
interest in enjoyable activities in the past month) or 3 
(feelings of  sadness or hopelessness or disinterest in 
enjoyable activities nearly every day for the past month). 
A total score of  greater than or equal to 3 is 83% sensitive 
and 92% specific for detecting depression (8). Risk of  
suicide is a serious concern so one should always ask if  
someone has thoughts of  killing him or herself  when 
screening for depression.
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Symptoms Sad or low mood OR• 
Loss of  interest in usually enjoyed • 
activities + 4 or more of  the symptoms 
included below:
Feelings of  guilt (feeling worthless/• 
hopeless)
Decreased energy• 
Motor slowing or agitation • 
Poor concentration• 
Disturbed sleep (too much or too little • 
sleep)
Excessively increased/decreased appetite• 
Thoughts of  harming/killing oneself  or • 







Severe symptoms of  depression include:
Psychosis (loss of  contact with reality):• 
a. Hallucinations (seeing or hearing 
things other people do not see or hear)
b. Delusions (beliefs that are firmly 
held despite being contradicted by what 
is generally accepted as reality
Activity level so low that daily function-• 
ing is impossible (Severely sad mood 
that results in lack of  desire to eat or 
drink or tend to personal hygiene)
Suicide • 
Table 1. Diagnostic criteria for depression
Depression 
Risk
     1. During the past month, have   
you   often been bothered by feeling sad, or     
hopeless? 
      2. During the past month, have you 
often felt little interest or pleasure in doing 
things? 
Not at all (0 points).• 
Nearly every day (3 points).• 
Suicide Risk 1. Have you had thoughts of  hurting 
or killing yourself ? If  yes, when, how often 
etc?
2. Do you have a plan to kill yourself ? 
What is your plan? (This will indicate likely 
risk). Do you have the means (methods) to 
do so?  
3. Have you ever tried to kill yourself ? 
If  yes, when and how? (This will give you an 
indication of  the severity of  prior attempts). 
Table 2. Screening questions for depression
post-traumatic Stress Disorder (ptSD)
PTSD may result from exposure to a stressful situation 
of  an exceptional nature (e.g. being the victim of  torture, 
rapes or beatings, observing or acting in armed conflict, 
or witnessing the violent death of  relatives or friends) (9). 
PTSD is a common disorder in individuals exposed to 
armed conflict and is common in South Sudan (4, 5, 10). 
Individuals with PTSD may experience physical symptoms 
associated with their stress. An example is a Sudanese 
refugee who presented with chronic abdominal and back 
pain. Medical causes were excluded and it was realized 
that his pain was part of  his PTSD which improved with 
antidepressant medication (11).  Depression and PTSD 
frequently occur together so one must screen for both 
conditions. Someone exposed to a traumatic event has 
PTSD if  they experience at least one symptom from 
cluster B, at least 3 symptoms from cluster C, and at least 
2 symptoms from cluster D consistently for at least one 
month and their symptoms cause significant disruption to 
their personal and professional life. (See tables 3 and 4)
treatment approach to patients with common 
Mental Disorders
As some medical conditions can present with or 
imitate psychiatric symptoms, it is important to first 
exclude common medical causes such as infection 
(malaria, typhoid, HIV), medication reactions, and 
toxic/metabolic or endocrine abnormalities (13). Once 
a psychiatric diagnosis is confirmed, you can consider 
treatment possibilities that typically include a combination 
of  medications and most importantly psychological and 
social interventions.  Medications may help but require 
close monitoring for side effects. (see table 5)
Community and Psychosocial Interventions: 
Psychosocial interventions in the form of  religious 
groups, friends, family and tribal structures, are some of  
the most important tools to help patients with depression 
and PTSD feel better. A review article on the mental 
health of  South Sudanese refugees in the Diaspora found 
that mechanisms of  coping with emotional distress, 
including encouraging connections with others, group 
social support and sharing experiences, helped to ease 
emotional difficulties (14). Health care providers can help 
patients feel better by (14):
• Focusing attention on positive things in the future 
and away from negative situations 
• Helping patients accept difficulties in life
• Helping patients create meaning from suffering
• Focusing patients on productive activities
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Table 4. Screening Questions for PTSD
If  willing, encourage the patient to talk about the trauma. 
Some people are not ready to share their story immediately. If  
this is the case, it is not recommended to force a person to tell 
their story. The patient may begin to feel more comfortable 
with time and eventually be ready to discuss their experience. 
Start by asking questions like: 
“Some people have difficult experiences like being attacked or threatened with 
a weapon; being raped; or seeing someone being badly injured or killed. Has 
anything like this ever happened to you?” 
IF YES:
“In the past 3 months, have you had recurrent dreams or nightmares about this 
experience, or recurrent thoughts or times when you felt as though it was happen-
ing again, even though it wasn’t?”
Symptoms CLUSTER B –1 or more of  the following 
symptoms for at least one month
Recurrent distressing memories of  the • 
event, including images or thoughts
Recurrent distressing dreams of  the event• 
Acting or feeling as if  the trauma was • 
recurring (includes a sense of  actually re-
living the event) 
Intense emotional distress when exposed • 
to something that reminds you of  the 
trauma
Physical symptoms like rapid heart rate, • 
sweating, and tremors when exposed to 
something that reminds you of  the trauma
CLUSTER C – 3 or more of  the following 
symptoms for at least one month
Avoiding thoughts, feelings, or • 
conversations associated with the trauma
Avoiding activities, places, or people that • 
cause you to remember the trauma
Inability to recall an important part of  the • 
trauma
Decreased interest or participation in • 
usually important activities
Feeling disconnected from others or • 
feeling alone when surrounded by family 
or friends
Limited range of  emotions (rarely able to • 
laugh or smile)
Sense of  no hope for the future (e.g., • 
does not expect to have a job, marriage, 
children)
CLUSTER D: 2 or more of  the following 
symptoms for at least one month
Hypervigilance (always on guard for • 
threats)
Easily startled or scared• 
Difficulty falling asleep or staying asleep• 
Irritability or outbursts of  anger• 
Difficulty concentrating• 
Table 3. Diagnostic Criteria for PTSD • Helping patients compare themselves with those 
who are less fortunate
Pharmacologic Interventions (15): There are few 
psychiatric medications available in South Sudan. 
Health care workers can use the following medications 
to treat depression and PTSD – which should be used 
in combination with community and psychosocial 
interventions., as shown in table 6.
Depression treatment
Refer to table 7.
ptSD treatment
Refer to table 8.
conclusion
Exposure to prolonged violence, displacement, and 
hardship has put the people of  South Sudan at risk of  
emotional distress. Therefore, it is essential for health 
care providers in South Sudan to focus on both physical 
and mental well-being. Advocacy, training, and research 
are desperately needed. Broad recommendations to 
strengthen mental health service provision are discussed 
in Part II. 
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Table 5. Treatment Algorithm
• EVALUATE presence of  symptoms 
• EXCLUDE common medical disorders that may cause psychiatric symptoms 
• CONSIDER the differential diagnoses for mental disorders based on the symptoms mentioned above
• START MEDICATION/PSYCHOSOCIAL INTERVENTION depending on the psychiatric illness
• ASSESS RESPONSE: See the patient back in clinic > assess presence of  symptoms and response to medication.  
 • If  complete resolution of  symptoms  > continue treatment at current dose 
• If  partial or no improvement > increase dose based on guidelines and reassess symptoms
• REASSESS RESPONSE frequently at the beginning of  treatment: 
a. If  complete resolution of  symptoms > continue medication at therapeutic dose for the recommended time frame            
 depending on the condition (please see table below).   
b. If  no response, worsening thoughts of  self-harm, or new psychotic symptoms > seek consultation with mental health  
 expert by any means necessary (including phone or internet)
Fluoxetine Amitriptyline Diazepam Chlorpromazine












(Treat by lowering 
dose) 
•Dry mouth, constipation, 
blurred vision, urinary reten-
tion
•Fatigue, weakness, dizziness, 
sedation •Sexual dysfunction
•Weight gain and increased 
appetite
•Sedation, fatigue, depression








•Low blood pressure, 
tachycardia
• Photosensitivity
Risks of  
Medication
•Skin rash (should 
stop the drug)





Overdose > respiratory de-
pression > coma







• Rare seizures •Neurolep-
tic malignant syndrome    
(Temperature >38°C, de-
lirium, sweating, rigid muscles, 
autonomic imbalance)
Reassess •Assess symp-
toms/ side effects 
every 2 weeks 
initially 
•Increase by 20mg 
to MAX dose every 
3-4 weeks if  no 
improvement
•Assess symptoms/ side ef-
fects every week initially
•Increase by 25mg every 3-7 
days to reach MAX dose if  no 
improvement 
•Assess symptoms/ side ef-
fects every 2-3 days initially
•Increase by 1-2mg every 2-3 
days up to MAX dose if  no 
improvement 
•Should be used for (no 
longer than 12-16 weeks) 
given high abuse/ depend-
ence potential 
•Taper by 1-2mg every 3-7 
days as withdrawal/ seizures 
can occur if  stopped abruptly 
•Assess symptoms and 
side effects every 1-2 days 
initially
•Increase by 20-50 mg/
day every 3-4 days
•Start lower/titrate slower 
in older patients
•Taper over 6-8 weeks to 
avoid rebound psychosis•Clinical response may be delayed up to several 
weeks after initiation
•Taper medication over >4 weeks) as withdrawal 
syndrome can occur if  stopped abruptly
*All medications should be used with caution in women of  childbearing age given possible teratogenic effects during pregnancy 
and lactation. The listed side effects are not exhaustive and all medications should be monitored closely.
Table 6. Pharmacologic Treatment for Depression and PTSD 
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sponse may be 
delayed)









•Fluoxetine is safer with fewer side effects 
than amitriptyline 
•If  improvement in symptoms treat at same 
dose for 6-12 months
•Consider maintenance (long-term) treatment 










•Increase dose until psychotic symptoms are 
controlled; after two weeks reduce to lowest 
effective dose (25 – 50mg IM can be used as 
needed for severe agitation)
Table 7: Depression Treatment
Target 
Symptoms





Chlorpromazine 30 – 75mg/daily
By mouth
200 – 800mg/day
At night or in divided doses. 









(Can start with 20mg every 
other day)
Amitriptyline 10– 25 mg/day 
By mouth 
10– 150 mg/day







•Use medications to target symptoms described by patient
•If  symptoms improve continue medication for at least 6-12 months except for di-
azepam given dependence/addiction potential
•If  symptoms recur, restart therapy and continue indefinitely
Table 8: PTSD treatment 
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